Yew Bio-Pharm Group, Inc.

OTCPK:YEWB Stock Report

Market Cap: US$10.3k

Yew Bio-Pharm Group Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Yew Bio-Pharm Group's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food Industry Growth16.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2021

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Yew Bio-Pharm Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:YEWB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 21290-10
30 Jun 21393-20
31 Mar 21344-10
31 Dec 2027110
30 Sep 2025010
30 Jun 2015000
31 Mar 20181-10
31 Dec 1928100
30 Sep 1930070
30 Jun 1944-190
31 Mar 1946-1100
31 Dec 1838-1100
30 Sep 1837-630
30 Jun 1835-530
31 Mar 1836320
31 Dec 1741320
30 Sep 17471010
30 Jun 17501010
31 Mar 1751110
31 Dec 1651210
30 Sep 1657510
30 Jun 1647520
31 Mar 1636520
31 Dec 1530520
30 Sep 1514420
30 Jun 1511420
31 Mar 158420
31 Dec 148410
30 Sep 148510
30 Jun 148410
31 Mar 148410
31 Dec 137410
30 Sep 137230
30 Jun 137230
31 Mar 137230
31 Dec 127230

Quality Earnings: Insufficient data to determine if YEWB has high quality earnings.

Growing Profit Margin: Insufficient data to determine if YEWB's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if YEWB's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare YEWB's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if YEWB's earnings growth over the past year exceeded the Food industry average.

Return on Equity

High ROE: YEWB has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/09 14:30
End of Day Share Price 2023/10/19 00:00
Earnings2021/09/30
Annual Earnings2020/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yew Bio-Pharm Group, Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution